 |
| Cherilyn Cecchini |
Dr. Cherilyn Cecchini, a pediatrician, author and influencer, has joined Finn Partners’ New York health group.
She did a five-year stint at LifeSci Communications, serving as its medical director and exiting as VP-account manager, and was physician chair-social media at the American Medical Women’s Assn.
Cecchini’s therapeutics expertise includes oncology, neurology, women’s health, cardiology and gene therapy.
She has contributed to Good Housekeeping; Parents Magazine; Business Insider; Eat This, Not That!; What to Expect; the Strategist; Romper and Babygaga.
“Cherilyn’s valuable insights into the physician-patient relationship, coupled with her experience as a communicator, writer and influencer, will enhance our practice’s ability to help clients solve their most complex challenges,” said Fern Lazar, global health practice leader at Finn Partners.
Cecchini reports to Tom Jones, head of the New York health and pharma sector.
Finn Partners took the No. 6 slot in O’Dwyer’s healthcare rankings with 2022 fees of $52.6M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
